Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons

Clinical trial NCT07050732 · RECRUITING

Trial details

NCT number: NCT07050732
Sponsor: Johns Hopkins University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2025-12-04
Primary completion: 2026-11-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.